ReviewBiomedicines2025

Is There a Role for Daratumumab Retreatment in Patients with Relapsed/Refractory Multiple Myeloma?

Davor Galusic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.